Documents
Federal rules and notices from the public comment record, analyzed continuously.
FDA ▾
Citizen Petition from University of Illinois, College of Pharmacy
0 comments
Analysis in progress
Top issues in comments
Citizen Petition from Katie Merkle
0 comments
Analysis in progress
Top issues in comments
Hemodialysis Blood Tubing - Sets-Premarket-Notification (510(k)) Submissions; Guidance for Industry and FDA Staff
0 comments
Analysis in progress
Top issues in comments
Forms FDA 3542a and FDA 3542: Questions and Answers; Guidance for Industry
0 comments
Analysis in progress
Top issues in comments
Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts; Guidance for Industry; Draft Guidance
0 comments
Analysis in progress
Top issues in comments
Andrew Jonathan Morgan: Final Debarment Order
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration Advisory Committees
0 comments
Analysis in progress
Top issues in comments
Modification of Certain Terminology in Title 21
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Proposed Collection; Comment Request; Time and Extent Applications for Nonprescription Drug Products
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Proposed Collection; Comment Request; Extralabel Drug Use in Animals
0 comments
Analysis in progress
Top issues in comments
Establishment of a Quantitative Medicine Innovation Network: Scope, Feasibility, and Opportunities; Request for Information
0 comments
Analysis in progress
Top issues in comments
Data Request (DR001): Use of the pH Cycling Test Model as a Testing Procedure for Fluoride Dentifrice Drug Products in Over-the-Counter (OTC) Monograph M021: Anticaries Drug Products for Over-the-Counter Human Use
0 comments
Analysis in progress
Top issues in comments
